Financial Statements — TRAX
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 168.02 | 248.47 |
| Total Current Assets | 177.75 | 289.40 |
| Property, Plant & Equipment | 1.07 | 1.17 |
| Total Non-current Assets* | 5.40 | 1.17 |
| Total Assets | 183.14 | 290.58 |
| Accounts Payable | 2.55 | 7.50 |
| Total Current Liabilities | 12.45 | 33.11 |
| Total Non-current Liabilities* | 1.90 | 0.00 |
| Total Liabilities* | 14.34 | 33.11 |
| Retained Earnings | (24.58) | -- |
| Total Stockholder Equity | 168.80 | 257.46 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Research & Development | 25.64 | 33.96 |
| Selling, General & Admin | 9.29 | 18.86 |
| Total Operating Expenses | 34.94 | 52.81 |
| Operating Income | (34.94) | (52.81) |
| Net Income | (33.37) | (50.48) |
| Basic EPS | (0.95) | -- |
| Diluted EPS | (0.95) | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (31.92) | (32.56) |
| Capital Expenditures | 0.03 | 0.02 |
| Free Cash Flow* | (31.94) | (32.58) |
| Investing Cash Flow | (0.02) | 34.98 |
| Financing Cash Flow | (48.51) | 7.85 |
* Derived from reported values
